Created in 2020 when Mylan merged with Pfizer's off-patent drug business, Upjohn.
In 2022, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of B-.
Source: CDP (2022)
The 2021 Antimicrobial Resistance (AMR) Benchmark ranks 17 large pharmaceutical companies on their efforts keep medicines and vaccines available, despite the rise of drug resistance. This company was identified as a leader amongst generic medicine manufacturers, receiving a score of 67%.
Source: Access to Medicine Foundation (2021)
In 2022, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of B.
Source: CDP (2022)
America's Most Responsible Companies 2022 by Newsweek and Statista recognises the Top 500 most responsible companies in the United States. Companies were evaluated in three areas: environmental (waste, energy use, etc.), social (leadership diversity, employees and philanthropy) and governance (transparency and economic performance). This company received a total score of 76.7/100, ranking 19th in the Health Care & Life Sciences sector, and 167th overall.
Source: Newsweek (2021)
JUST Capital polls Americans every year to identify the issues that matter most in defining just business behaviour. For their 2023 rankings JUST Capital asked a representative sample of 3,002 Americans to compare 20 different business Issues on a head-to-head basis, producing a reliable hierarchy of Issues ranked in order of priority. Issues are organised under the headings Workers, Customers, Communities, the Environment, or Shareholders & Governance. JUST Capital then define metrics that map to those issues and track and analyse the largest, publicly traded U.S. companies. This analysis powers their rankings, in which this company ranked 827th of 951 companies, and 39th of 41 Pharmaceuticals & Biotech companies.
Source: JUST Capital (2023)
This company received an S&P Global ESG Score of 30/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 18 Nov 2022). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2022)
As You Sow's 2023 report, 'The 100 Most Overpaid CEOs', reveals the 100 most overpaid CEOs from USA's 500 largest public companies (as determined by the S&P 500 list). This company's CEO, Michael Goettler came in at number 53 on the list, having been paid US$14,669,592 in 2022. According to the report, "Most CEOs have come to be grossly overpaid, and that overpayment is harmful to the companies, the shareholders, the customers, the other employees, the economy, and society as a whole."
Source: As You Sow (2023)
This company is a member of the AMR Industry Alliance, a coalition of biotech, diagnostics, generics and research-based pharmaceutical companies set up to provide sustainable solutions to curb antimicrobial resistance (AMR). AMR is an increasingly significant threat to global public health which puts at risk the effective prevention and treatment of a wide range of infections.
Source: AMR Industry Alliance (2021)
This company has corporate social responsibility claims on its website.
Source: company website (2021)
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
Source: company website (2020)
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
Source: Open Secrets (2020)
|Revenue||20 billion USD (2020)|
One the world's largest manufacturers of prescription generic drugs. Merged with Upjohn in 2020 to create Viatris Inc.
- Meda AB
Pharmaceutical manufacturer and marketer
Products are prescription and OTC (over the counter) drugs. Main focus is on sales and marketing and as they do not develop early stage new products, new product growth is by acquisition. Products are sold in more than 150 countries, with own sales companies in 60 countries. Product areas are respiratory, dermatological and pain/inflammation. Acquired by Mylan in 2016.
- Alphapharm Pty Ltd
Established in 1982. Makers of generic medicines. Alphapharm is the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme. Operates a manufacturing plant in Queensland. Acquired by Mylan in 2007 who merged with Upjohn in 2020 to form Viatris. Bought Aspen's portfolio of prescription and over-the-counter products in Australia for $188 million in 2019.
Products / BrandsViatris Australia
Dermeze Skin Care
Dermeze Body Wash
Dymadon Pain Relief Tablets
Gastro-Stop Digestive Care
Irish Moss Cold & Flu
Tums Digestive Care
Waxsol Eye & Ear Care
Zantac Digestive Care